Abstract
The investigation is based upon mitotic counts in malignant tumours following injection of a mitotic inhibitor. Between the clinical growth and the cell proliferation there is, however, a considerable discrepancy, which can only be explained by a very substantial cell loss. The cell loss is discussed.

This publication has 4 references indexed in Scilit: